Cerebrospinal fluid levels of CXCL13 are elevated in neuromyelitis optica

Journal of Neuroimmunology

Volumn 240-241, Issue , 2011, Pages 104-108

  Zhong, Xiaonan ^a   Wang, Honghao ^a   Dai, Yongqiang ^a   Wu, Aimin ^a   Bao, Jian ^a   Xu, Wen ^a   Cheng, Chen ^a   Lu, Zhengqi ^a   Qiu, Wei ^a   Hu, Xueqiang ^a  

^a THE THIRD AFFILIATED HOSPITAL OF SUN YAT SEN UNIVERSITY   (China)

Author keywords

Cerebrospinal fluid; CXCL13; Multiple sclerosis; Neuromyelitis optica

Indexed keywords

CXCL13 CHEMOKINE;

ADOLESCENT; ADULT; ARTICLE; CERVICAL SPONDYLOSIS; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DISABILITY; DISEASE ACTIVITY; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; EXPANDED DISABILITY STATUS SCALE; FEMALE; HUMAN; HUMAN CELL; LEUKOCYTE COUNT; MALE; MULTIPLE SCLEROSIS; MYELOOPTIC NEUROPATHY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN CEREBROSPINAL FLUID LEVEL; RELAPSE; SCHOOL CHILD;

ADOLESCENT; ADULT; B-LYMPHOCYTE SUBSETS; CHEMOKINE CXCL13; CHILD; DISABILITY EVALUATION; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS, RELAPSING-REMITTING; NEUROMYELITIS OPTICA; UP-REGULATION; YOUNG ADULT;

EID: 83555176356     PISSN: 01655728     EISSN: 18728421     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2011.10.001     Document Type: Article

References (28)

1. Archelos J.J., Storch M.K., Hartung H.P. The role of B cells and autoantibodies in multiple sclerosis. Ann. Neurol. 2000, 47:694-706.
2. Bedi G.S., Brown A.D., Delgado S.R., Usmani N., Lam B.L., Sheremata W.A. Impact of rituximab on relapse rate and disability in neuromyelitis optica. Mult. Scler. 2011, [Epub ahead of print]. 10.1177/1352458511404586.
3. Brucklacher-Waldert V., Stuerner K., Kolster M., Wolthausen J., Tolosa E. Phenotypical and functional characterization of T helper 17 cells in multiple sclerosis. Brain 2009, 132(Pt 12):3329-3341.
4. Cree B.A., Lamb S., Morgan K., Chen A., Waubant E., Genain C. An open label study of the effects of rituximab in neuromyelitis optica. Neurology 2005, 64:1270-1272.
5. Dale R.C., Tantsis E., Merheb V., Brilot F. Cerebrospinal fluid B-cell expansion in longitudinally extensive transverse myelitis associated with neuromyelitisoptica immunoglobulin G. Dev. Med. Child Neurol. 2011, 47:856-860.
6. Festa E.D., Hankiewicz K., Kim S., Skurnick J., Wolansky L.J., Cook S.D., Cadavid D. Serum levels of CXCL13 are elevated in active multiple sclerosis. Mult. Scler. 2009, 15:1271-1279.
7. Gunn M.D., Ngo V.N., Ansel K.M., Ekland E.H., Cyster J.G., Williams L.T. A B-cell-homing chemokine made in lymphoid follicles activates Burkitt's lymphoma receptor-1. Nature 1998, 391:799-803.
8. Khademi M., Kockum I., Andersson M.L., Iacobaeus E., Brundin L., Sellebjerg F., Hillert J., Piehl F., Olsson T. Cerebrospinal fluid CXCL13 in multiple sclerosis: a suggestive prognostic marker for the disease course. Mult. Scler. 2011, 17:335-343.
9. Krumbholz M., Theil D., Cepok S., Hemmer B., Kivisäkk P., Ransohoff R.M., Hofbauer M., Farina C., Derfuss T., Hartle C., Newcombe J., Hohlfeld R., Meinl E. Chemokines in multiple sclerosis: CXCL12 and CXCL13 up-regulation is differentially linked to CNS immune cell recruitment. Brain 2006, 129(Pt 1):200-211.
10. Lennon V.A., Kryzer T.J., Pittock S.J., Verkman A.S., Hinson S.R. IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel. J. Exp. Med. 2005, 202. 473-177.
11. Li Y., Wang H., Long Y., Lu Z., Hu X. Increased memory Th17 cells in patients with neuromyelitis optica and multiple sclerosis. J. Neuroimmunol. 2011, 234:155-160.
12. Link H., Tibbling G. Principles of albumin and IgG analyses in neurological disorders. III. Evaluation of IgG synthesis within the central nervous system in multiple sclerosis. Scand. J. Clin. Lab. Invest. 1977, 37:397-401.
13. Ljostad U., Mygland A. CSF B-lymphocyte chemoattractant (CXCL13) in the early diagnosis of acute Lyme neuroborreliosis. J. Neurol. 2008, 255:732-737.
14. Magliozzi R., Howell O., Vora A., Serafini B., Nicholas R., Puopolo M., et al. Meningeal B-cell follicles in secondary progressive multiple sclerosis associate with early onset of disease and severe cortical pathology. Brain 2007, 130:1089-1104.
15. Nandhagopal R., Al-Asmi A., Gujjar A.R. Neuromyelitis optica: an overview. Postgrad. Med. J. 2010, 86:153-159.
16. Pellkofer H.L., Krumbholz M., Berthele A., Hemmer B., Gerdes L.A., Havla J., et al. Long-term follow-up of patients with neuromyelitis optica after repeated therapy with rituximab. Neurology 2011, 76:1310-1315.
17. Polman C.H., Reingold S.C., Banwell B., Clanet M., Cohen J.A., Filippi M., et al. Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann. Neurol. 2011, 69:292-302.
18. Prineas J.W. Multiple sclerosis: presence of lymphatic capillaries and lymphoid tissue in the brain and spinal cord. Science 1979, 203:1123-1125.
19. Ragheb S., Li Y., Simon K., Vanhaerents S., Galimberti D., De Riz M., et al. Multiple sclerosis: BAFF and CXCL13 in cerebrospinal fluid. Mult. Scler. 2011, 17:819-829.
20. Ransohoff R.M., Kivisakk P., Kidd G. Three or more routes for leukocyte migration into the central nervous system. Nat. Rev. Immunol. 2003, 3:569-581.
21. Rioja I., Hughes F.J., Sharp C.H., Warnock L.C., Montgomery D.S., Akil M., et al. Potential novel biomarkers of disease activity in rheumatoid arthritis patients: CXCL13, CCL23, transforming growth factor alpha, tumor necrosis factor receptor superfamily member 9, and macrophage colony-stimulating factor. Arthritis Rheum. 2008, 58:2257-2267.
22. Rupprecht T.A., Pfister H.W., Angele B., Kastenbauer S., Wilske B., Koedel U. The chemokine CXCL13 (BLC): a putative diagnostic marker for neuroborreliosis. Neurology 2005, 65:448-450.
23. Rupprecht T.A., Kirschning C.J., Popp B., Kastenbauer S., Fingerle V., Pfister H.W., et al. Borrelia garinii induces CXCL13 production in human monocytes through Toll-like receptor 2. Infect. Immun. 2007, 75:4351-4356.
24. Sellebjerg F., Börnsen L., Khademi M., Krakauer M., Olsson T., Frederiksen J.L., et al. Increased cerebrospinal fluid concentrations of the chemokine CXCL13 in active MS. Neurology 2009, 73:2003-2010.
25. Serafini B., Rosicarelli B., Magliozzi R., Stigliano E., Aloisi F. Detection of ectopic B-cell follicles with germinal centers in the meninges of patients with secondary progressive multiple sclerosis. Brain Pathol. 2004, 14:164-174.
26. Watanabe S., Nakashima I., Misu T., Miyazawa I., Shiga Y., Fujihara K., et al. Therapeutic efficacy of plasma exchange in NMO-IgG-positive patients with neuromyelitis optica. Mult. Scler. 2007, 13:128-132.
27. Widney D.P., Breen E.C., Boscardin W.J., Kitchen S.G., Alcantar J.M., Smith J.B., et al. Serum levels of the homeostatic B cell chemokine, CXCL13, are elevated during HIV infection. J. Interferon Cytokine Res. 2005, 25:702-706.
28. Wingerchuk D.M., Lennon V.A., Pittock S.J., Lucchinetti C.F., Weinshenker B.G. Revised diagnostic criteria for neuromyelitis optica. Neurology 2006, 66:1485-1489.